Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Testori · SciRah

Researcher profile · Semantic Scholar

M. Testori

Share profile

M. Testori — researcher profile on SciRah

h-index: 5
Works: 17
Citations: 116

Most-cited papers

Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
J. Medina-Echeverz, M. Hinterberger, M. Testori, M. Geiger +10 more
2019Nature Communications38 citations Open access
Semantic Scholar
Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
J. Julander, M. Testori, C. Cheminay, A. Volkmann
2018Frontiers in Immunology26 citations Open access
Semantic Scholar
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring
Julie Berthe, Pawan Poudel, F. Segerer, E. Jennings +15 more
2024Frontiers in Immunology24 citations Open access
Semantic Scholar
NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin
Stéphanie L. Sanos, R. Kassub, M. Testori, M. Geiger +10 more
2018Frontiers in Immunology19 citations Open access
Semantic Scholar
VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics
F. Lori, D. De Forni, E. Katabira, D. Baev +6 more
2012PLoS ONE6 citations Open access
Semantic Scholar
1505 Spatial profiling of the SCLC tumor microenvironment defined by high MHC-I expression reveals association with functionally relevant antigen presentation
Miljenka Vuko, F. Segerer, Mingchao Xie, M. A. Gavaldon +15 more
2023Regular and Young Investigator Award Abstracts1 citations Open access
Semantic Scholar
P04.02 A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies
M. Hinterberger, J. Medina-Echeverz, M. Testori, M. Geiger +10 more
2020Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
Prognostic immunoprofiling of muscle invasive bladder cancer (MIBC) patients in a multicentre setting
K. Nekolla, N. Brieu, Christos G. Gavriel, M. Widmaier +16 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis
James Boyle, Jan Zaucha, Felicia Ng, A. Spitzmüller +17 more
2025Cancer Research Communications0 citations Open access
Semantic Scholar
Abstract 1711: A multi-modal analysis approach leveraging multiplexed spatial phenotyping and multi-omics analysis to better understand the prognostic value of tertiary lymphoid structures in non-small cell lung cancer
J. Berthe, F. Segerer, Emily C. Jennings, Alma Andoni +14 more
2022Cancer Research0 citations
Semantic Scholar
155 MHC class I antigen presentation is associated with an inflamed SCLC tumor microenvironment characterized by a higher density of cytotoxic T-cells in closer proximity to tumor cells
M. Schick, Miljenka Vuko, Mingchao Xie, M. A. Gavaldon +14 more
2022Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
FP07.02 Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC
A. Haragan, K. Nekolla, A. Kapil, N. Brieu +12 more
20210 citations Open access
Semantic Scholar
39 A multi-modal analysis approach leveraging multiplexed spatial phenotyping and multi-omics analysis to better understand the prognostic value of tertiary lymphoid structures in NSCLC
J. Berthe, S. Sridhar, F. Segerer, M. Testori +15 more
2021Journal for ImmunoTherapy of Cancer0 citations Open access
Semantic Scholar
A NOVEL CANCER IMMUNOTHERAPY COMBINES RMVA-CD40L WITH TUMOR TARGETING ANTIBODIES
M. Hinterberger, J. Medina-Echeverz, M. Testori, M. Geiger +9 more
20190 citations
Semantic Scholar
52PA novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors
J. Medina, M. Hinterberger, M. Testori, M. Geiger +4 more
20180 citations Open access
Semantic Scholar
A novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors
J. Medina, M. Hinterberger, M. Testori, M. Geiger +8 more
20180 citations
Semantic Scholar
Abstract 727: A novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors
J. Medina-Echeverz, M. Hinterberger, M. Testori, M. Geiger +4 more
2018Immunology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Geiger×7
Invite
M. Geiger — researcher profile on SciRah
R. Giessel×7
Invite
R. Giessel — researcher profile on SciRah
H. Hochrein×7
Invite
H. Hochrein — researcher profile on SciRah
H. Lauterbach×7
Invite
H. Lauterbach — researcher profile on SciRah

M. Hinterberger

×6

Invite

M. Hinterberger — researcher profile on SciRah

Invite

P. Chaplin — researcher profile on SciRah

Invite

F. Segerer — researcher profile on SciRah

Invite

B. Bathke — researcher profile on SciRah

Invite

R. Kassub — researcher profile on SciRah

Miljenka Vuko×5

Invite

Miljenka Vuko — researcher profile on SciRah

A. Spitzmüller×5

Invite

A. Spitzmüller — researcher profile on SciRah

J. Medina-Echeverz×4

Invite

J. Medina-Echeverz — researcher profile on SciRah